Alvotech (ALVOW) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.
Les analystes estiment Bénéfice par action (EPS) de $-0.13 et chiffre d'affaires de $0.45B pour le prochain exercice fiscal.
Historique du Bénéfice par action (EPS): 2024: réel $-0.87 vs est $-0.13 (manqué -593.3%). 2025: réel $0.10 vs est $-0.08 (dépassé +223.1%). Précision des analystes: 0%.
Estimations du BPA — ALVOW
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$0.87
vs Est –$0.13
▼ 85.6% off
2025
Actual $0.10
vs Est –$0.08
▲ 181.2% off
Profitability Outlook
Company has mixed profitability — some years profitable, some at a loss. EPS trend is improving.
Estimations du CA — ALVOW
96%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.490B
vs Est $0.454B
▲ 7.2% off
2025
Actual $0.586B
vs Est $0.581B
▲ 0.9% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
Les autres consultent aussi
